“Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha” (2014) Bangladesh Journal of Pharmacology, 9(2), pp. 208–217. doi:10.3329/bjp.v9i2.18180.